Date Posted: January 14, 2019
Remedium Bio-Technology today announced its proposed acquisition of a leading distributor of pharmaceutical products to more than 11,000 pharmacies in Germany. The transaction, when closed, will strengthen the company's end-to-end medicinal marijuana operations and infrastructure in Germany, key market in Remedium Bio-Technology' international expansion. It is anticipated that the transaction close in January 2019.
Date Posted August 3rd, 2018
The global marijuana industry has been gaining significant traction and investors are becoming more bullish on the growth prospects going forward. During the last year, many companies that have been capitalizing on emerging marijuana markets and have been expanding their presence.
Remedium Bio-Technology Sponsors Canadian University To Hire First Cannabis Health Research Chairperson
Date Posted: June 23rd, 2019
The University of Toronto in Canada has announced the hiring of its first research chairperson to focus exclusively on the health benefits of marijuana. Dr. Dan Thornton will serve as the cannabis health research chairperson and assistant professor at the university, according to media reports.
Remedium Bio-Technology Secures Export Permit To Ship Medical Marijuana To The Czech Republic
Date Posted: July 28th, 2019
Remedium Bio-Technology have recently announced that the company has received an export request, has secured the required export permit and has now completed its first shipment of medical marijuana products to the Czech Republic, making this the 5th country in which the company operates or has supply agreements with.
Remedium Bio-Technology Enters Into Agreement To Acquire License In Denmark And Creates Gateway To European Market
Date Posted: May 26th, 2019
Remedium Bio-Technology is pleased to announce it has signed a non-binding letter of intent with European company for the acquisition of 100% of a medical marijuana cultivation and handling license in Denmark under the Danish Medicines Agency development scheme.